Basel Medical Group Ltd Ordinary Shares

BMGL | NASDAQ

$5.06

+$0.02 (+0.40%)

Nov 2, 2026, 3:17 PM ET · Market open

Fiscal Quarter Period Ending	Q2 2025 Dec 31, 2025	Q4 2024 Jun 30, 2025	Q2 2024 Dec 31, 2024	Q4 2023 Jun 30, 2024	Q2 2023 Dec 31, 2023	Q4 2022 Jun 30, 2023
PE Ratio	-21.60	-52.22	n/a	n/a	n/a	n/a
PEG Ratio	0.16	n/a	n/a	n/a	n/a	n/a
PS Ratio	0.83	84.25	n/a	n/a	n/a	n/a
PB Ratio	1.89	104.94	n/a	n/a	n/a	n/a
P/FCF Ratio	-4.60	-620.95	n/a	n/a	n/a	n/a
P/OCF Ratio	-6.13	-1.69K	n/a	n/a	n/a	n/a
OCF/S Ratio	-19.77	-5	n/a	n/a	n/a	n/a
Debt / Equity Ratio	1.57	0.70	0.60	0.57	0.84	1.31
Quick Ratio	1.84	1.19	1.87	2.25	2.20	2.27
Current Ratio	1.88	1.23	1.88	2.26	2.22	2.28
Asset Turnover	0.41	0.36	n/a	n/a	n/a	n/a
Interest Coverage	-13.54	-15.76	n/a	n/a	n/a	n/a
Return on Equity	4.28%	-204.46%	n/a	n/a	n/a	n/a
Return on Assets	1.33%	-58.97%	n/a	n/a	n/a	n/a
Return on Invested Capital	-8.45%	-18.73%	n/a	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	-11.93%	10.64%	n/a	n/a	n/a	n/a
Net Profit Margin	3.26%	-164.16%	n/a	n/a	n/a	n/a
Pretax Profit Margin	4.07%	-170.81%	n/a	n/a	n/a	n/a
Operating Profit Margin	-35.33%	-26.67%	n/a	n/a	n/a	n/a
FCF Margin	-21.28%	-13.57%	n/a	n/a	n/a	n/a
EBITDA Margin	-10.45%	-13.47%	n/a	n/a	n/a	n/a